NEUROPACE, INC. (NPCE)

Every figure this model derived for NPCE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 369,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 51,699,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 86,193,000 AssetsCurrent 2026-06-30
current liabilities 17,433,000 LiabilitiesCurrent 2026-06-30
equity 11,883,000 StockholdersEquity 2026-06-30
interest expense 6,305,000 InterestExpenseNonoperating 2026-06-30
ocf -11,241,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 98,836,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 9,816,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NPCE on one particular measure came for.

RatioValue
cash operating margin-4.98
current ratio4.98
current ratio reported4.94
deferred revenue growth-82.33
dilution pct12.36
fcf margin-11.75
growth cv0.72
interest cover-2.39
operating margin-15.26
owner earnings margin-21.68
revenue growth16.9
revenue growth per share4.04
roic-62.05
rpo growth0.0
rule of 401.64
sbc pct revenue9.93

What to be careful about

What this model itself distrusts about NPCE's figures. Written by the derivation as it ran, not added afterwards.